Patent ID: 7435828

Claim:
A pharmaceutical composition containing at least one thiazolidin-4-one derivative of the Formula (I) wherein: R 1 represents a phenyl group independently mono-, di- or trisubstituted with lower alkyl, halogen, lower alkoxy, or —CF 3 ; R 2 represents lower alkyl; allyl; cyclopropyl; cyclobutyl; cyclopentyl; or mono- or di-lower alkylamino; R 3 represents —-O—CR 7 R 8 —CR 9 R 10 —(CR 11 R 12 ) n —O—R 13 ; R 4 represents hydrogen; hydroxy; lower alkoxy; lower alkyl; or halogen; R 5 and R 6 each represents independently lower alkyl; R 7 represents hydrogen, lower alkyl, or hydroxymethyl; R 8 , R 9 , R 11 and R 12 each represents independently hydrogen or methyl; R 10 represents hydrogen or lower alkyl; in case n represents the integer 1, R 10 in addition represents lower alkoxy, hydroxy, —NH 2 , —NHR 5 or —NR 5 R 6 ; R 13 represents hydrogen; lower alkyl; hydroxycarbonyl-lower alkyl; 1-glyceryl or 2-glyceryl; n represents the integer 0 or 1; or configurational isomers, optically pure enantiomers, mixtures of enantiomers, enantiomeric racemates, diastereomers, mixtures of diastereomers, diastereomeric racemates, mixtures of diastereomeric racemates, or a meso-form thereof, or pharmaceutically acceptable salts thereof, and inert carrier material.